PAR 3.64% 28.5¢ paradigm biopharmaceuticals limited..

PAR General discussion, page-253

  1. 146 Posts.
    lightbulb Created with Sketch. 21
    I suspect that there is enough shareholder dissatisfaction right now that the upcoming remuneration vote will probably be rejected for the second time. Not sure whether a board spill is a good or bad thing. In the short term, probably bad for the shareprice. But in the longer term?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.